Dr. Francisca Kartono, DO, is a board-certified dermatologist practicing in Canton and Brighton, MI.
Dr. Kartono graduated with honors from UCLA with a Bachelor of Science in Biochemistry. She received her osteopathic medical school training from Western University of Health Sciences in Pomona, CA. She then made a move to Michigan and completed her internship at Henry Ford Hospital and her dermatology residency training at Botsford and Pontiac Osteopathic Hospitals through Michigan State University. After completing her dermatology residency, she subsequently pursued a fellowship at the Ohio State University Medical Center with a focus on cutaneous lymphoma. Previously, Dr. Kartono has served as assistant clinical professor in Dermatology at the Wexner Ohio State University Medical Center.
Dr. Kartono has numerous dermatology publications, lectured at national meetings, and was involved with clinical trials in psoriasis, hidradenitis suppurativa, and lupus. She enjoys treating various general medical and surgical dermatology concerns, as well as administering phototherapy treatments for her patients.
Dr. Kartono lives in Canton with her husband and has made Michigan her permanent home.
Medical Dermatology Update
- Understand the studies showing associations between chronic inflammatory skin disease and cardiovascular disease risk factors
- Review current guidelines and recommendations in the management of atopic dermatitis, psoriasis and hidradenitis suppurativa
- Review the efficacy and safety concerns with new and current biologic agents for chronic inflammatory skin disease
- New advances in dermatologic treatment
- New methods of diagnosis or treatment
- Availability of new medication(s) or indication(s)
- Development of new technology
- Advances in medical knowledge
- Boguniewicz M et al. “Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape”. Ann Allergy Ashtma Immunol. 2018 Jan;120(1):10-22.e2.
- Ungar B, et al. “An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease”. J Invest Dermatol. 2017 Mar;137(3):603-613.
- Armstrong AW, et al. “From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis”. J Am Acad Dermatol. 2017 Feb;76(2):290-298.
Core Competencies: 2, 3, 6, 7